What does Apotheek Popelier do?

Apotheek Popelier is a pharmacy in Brugge. Private Limited, started on 9 November 1990, 1 establishment.

What is the address of Apotheek Popelier?

The registered office of Apotheek Popelier is located at Dorpsstraat 4a, 8200 Brugge.

Is Apotheek Popelier still active?

Yes. According to the CBE (31 October 2026) Apotheek Popelier is active, legal situation “Normale toestand”, started on 9 November 1990.

Is Apotheek Popelier registered on Peppol?

Yes, Apotheek Popelier is registered on the Peppol network with ID 0208:0441997821.

What is the enterprise number of Apotheek Popelier?

The enterprise number of Apotheek Popelier is BE0441997821.

When was Apotheek Popelier founded?

Apotheek Popelier was founded on 9 November 1990.

Who are the directors of Apotheek Popelier?

According to the 2025 annual accounts, the directors of Apotheek Popelier are: REBA PHARMA, VEMAPHAR.

Is Apotheek Popelier a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 9 November 1990; 4 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did Apotheek Popelier make in 2025?

Apotheek Popelier posted a profit after taxes of € 61,942 in financial year 2025.

What is the revenue of Apotheek Popelier?

As a small company, Apotheek Popelier is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 170,908.

How much does an employee at Apotheek Popelier earn?

The average wage cost per full-time employee at Apotheek Popelier was € 64,600 in 2023: staff costs of € 64,629 for 1 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does Apotheek Popelier have?

According to the 2025 annual accounts, Apotheek Popelier has 0 full-time equivalents (FTE).

Apotheek Popelier (Private Limited) - Brugge

Dossier Apotheek Popelier, printed on 31 October 2026 from databakkes.be/en/0441997821/apotheek-popelier. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Apotheek Popelier from Brugge, company number BE0441997821, closed financial year 2025 with a result of € 61,942 after tax. For that financial year Apotheek Popelier recorded a gross margin of € 170,908 and equity of € 521,839. Compared with financial year 2024, the result moved from € 64,217 to € 61,942. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 2, 2026.

What it is worth Growing

€ 521,839

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 61,942

▼ 4% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 87,251

▲ 5% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 61,000 paid out

98 % of the profit went to the shareholders, mostly to VEMAPHAR (50 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 72,500

▲ 8% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2025

Bank debt ≈ 5 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 57,467

▼ 15% vs 2024

€ 10,712 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.

Owed to suppliers

€ 126,886

▼ 4% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 15,682

▲ 87% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 178,317 Gross margin 2022: € 178,317 First fiscal year in the series	€ 127,504 Gross margin 2023: € 127,504 ▼ 28% vs 2022 (€ 178,317) Unfavourable step	€ 164,997 Gross margin 2024: € 164,997 ▲ 29% vs 2023 (€ 127,504) Favourable step	€ 170,908 Gross margin 2025: € 170,908 ▲ 4% vs 2024 (€ 164,997) Favourable step	▲ 4%
Profit after taxes	€ 83,177 Profit after taxes 2022: € 83,177 First fiscal year in the series	€ 31,636 Profit after taxes 2023: € 31,636 ▼ 62% vs 2022 (€ 83,177) Unfavourable step	€ 64,217 Profit after taxes 2024: € 64,217 ▲ 103% vs 2023 (€ 31,636) Favourable step	€ 61,942 Profit after taxes 2025: € 61,942 ▼ 4% vs 2024 (€ 64,217) Unfavourable step	▼ 4%
Equity	€ 517,545 Equity 2022: € 517,545 First fiscal year in the series	€ 519,181 Equity 2023: € 519,181 Unchanged (€ 517,545) Favourable step	€ 520,898 Equity 2024: € 520,898 Unchanged (€ 519,181) Favourable step	€ 521,839 Equity 2025: € 521,839 Unchanged (€ 520,898) Favourable step
Total debts	€ 216,220 Total debts 2022: € 216,220 First fiscal year in the series	€ 236,200 Total debts 2023: € 236,200 ▲ 9% vs 2022 (€ 216,220) Unfavourable step	€ 272,349 Total debts 2024: € 272,349 ▲ 15% vs 2023 (€ 236,200) Unfavourable step	€ 262,406 Total debts 2025: € 262,406 ▼ 4% vs 2024 (€ 272,349) Favourable step	▼ 4%
Cash	€ 101,380 Cash 2022: € 101,380 First fiscal year in the series	€ 79,687 Cash 2023: € 79,687 ▼ 21% vs 2022 (€ 101,380) Unfavourable step	€ 83,348 Cash 2024: € 83,348 ▲ 5% vs 2023 (€ 79,687) Favourable step	€ 87,251 Cash 2025: € 87,251 ▲ 5% vs 2024 (€ 83,348) Favourable step	▲ 5%
Land & buildings	€ 398,170 Land & buildings 2022: € 398,170 First fiscal year in the series	€ 423,830 Land & buildings 2023: € 423,830 ▲ 6% vs 2022 (€ 398,170) Unchanged	€ 434,927 Land & buildings 2024: € 434,927 ▲ 3% vs 2023 (€ 423,830) Unchanged	€ 407,832 Land & buildings 2025: € 407,832 ▼ 6% vs 2024 (€ 434,927) Unchanged	▼ 6%
Retained profit	€ 498,945 Retained profit 2022: € 498,945 First fiscal year in the series	€ 500,581 Retained profit 2023: € 500,581 Unchanged (€ 498,945) Favourable step	€ 502,298 Retained profit 2024: € 502,298 Unchanged (€ 500,581) Favourable step	€ 503,239 Retained profit 2025: € 503,239 Unchanged (€ 502,298) Favourable step
Dividend	€ 83,000 Dividend 2022: € 83,000 First fiscal year in the series	€ 30,000 Dividend 2023: € 30,000 ▼ 64% vs 2022 (€ 83,000) Unchanged	€ 62,500 Dividend 2024: € 62,500 ▲ 108% vs 2023 (€ 30,000) Unchanged	€ 61,000 Dividend 2025: € 61,000 ▼ 2% vs 2024 (€ 62,500) Unchanged	▼ 2%
Bank debt	€ 53,569 Bank debt 2022: € 53,569 First fiscal year in the series	€ 65,693 Bank debt 2023: € 65,693 ▲ 23% vs 2022 (€ 53,569) Unfavourable step	€ 67,574 Bank debt 2024: € 67,574 ▲ 3% vs 2023 (€ 65,693) Unfavourable step	€ 57,467 Bank debt 2025: € 57,467 ▼ 15% vs 2024 (€ 67,574) Favourable step	▼ 15%
Balance sheet total	€ 733,764 Balance sheet total 2022: € 733,764 First fiscal year in the series	€ 755,381 Balance sheet total 2023: € 755,381 ▲ 3% vs 2022 (€ 733,764) Unchanged	€ 793,247 Balance sheet total 2024: € 793,247 ▲ 5% vs 2023 (€ 755,381) Unchanged	€ 784,245 Balance sheet total 2025: € 784,245 ▼ 1% vs 2024 (€ 793,247) Unchanged	▼ 1%
Employees (FTE)	-	1 Employees (FTE) 2023: 1 First fiscal year in the series	0 Employees (FTE) 2024: 0 ▼ 1 vs 2023 (1) Unchanged	0 Employees (FTE) 2025: 0 Unchanged (0) Unchanged

Key figures of Apotheek Popelier, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.

What happened to Apotheek Popelier?

What happened at Apotheek Popelier in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Apr 2, 2026 New annual accounts for financial year 2025: profit of € 61,942 (▼ 4% vs 2024). Source: NBB ↗
Dec 26, 1990 New establishment in Brugge. KBO
Nov 9, 1990 Start of the company according to the CBE. KBO

In short

From € 83,177 profit in 2022 to € 61,942 profit in 2025.

Paid € 2,623 in corporate taxes since 2022.

Best year ever: 2022, with € 83,177 profit.

On average € 127,500 of value added per employee in 2023.

Original PDFs at the National Bank ↗

Management

VEMAPHAR 50%

The stake of VEMAPHAR comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

Apotheek Popelier

Behind Apotheek Popelier are REBA PHARMA and VEMAPHAR. The shares are held by VEMAPHAR (50%).

Directors

According to the 2025 annual accounts

REBA PHARMA

Director · represented by Popelier Bieke

VEMAPHAR

Director · represented by Verbeke Koen

Also active at: SANOPHAR, APOTHEEK MAERTENS, Farmave

Shareholders

VEMAPHAR

50%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Dorpsstraat 4a

8200 Brugge

2.050.957.904

Dorpsstraat 4 A

8200 Brugge

Active since 26 December 1990

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0441.997.821

VAT number

BE 0441.997.821

Registered office

Dorpsstraat 4a, 8200 Brugge

Names & denominations

Apotheek Popelier

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

9 November 1990

Peppol

Active · Active since 30 Sept 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

Verhuur en exploitatie van eigen of geleased residentieel onroerend goed, exclusief sociale woningen

View on CBE Public ↗ Annual accounts (NBB) ↗

Apotheek Popelier

Financials

What happened to Apotheek Popelier?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Details

Frequently asked questions